Search the Newsreel

Why Novartis, Lilly, and Bristol Myers Are Eyeing This Clinical-Stage Cancer Play

Quick Read AKTS retains full worldwide rights to its alpha-emitting cancer platform, with $517M cash and binary Q1 2027 trial data looming. NVS, whose Pluvicto grew 43% in Q2 2026, and LLY, already a $60M upfront partner, rank as the top two strategic acquirers. …

Eli Lilly, Novo Nordisk Battle It Out In Weight-Loss Pills Market

The weight-loss pills battle between Eli Lilly and Novo Nordisk could add to the projected $200 billion market for obesity drugs. Continue Reading

BMO initiates Exelixis stock at Market Perform, cites patent cliff

BMO Capital initiated coverage on Exelixis (NASDAQ:EXEL) with a Market Perform rating and a $54.00 price target, citing concerns about a patent cliff in early 2030 for its main drug, cabozantinib. While the company's financial health is strong, BMO remains cautious as the follow-up …

JLB & Associates Inc. Acquires Shares of 48,849 Exelixis, Inc. $EXEL

JLB & Associates Inc. has purchased 48,849 shares of Exelixis, Inc. (NASDAQ:EXEL) for approximately $2.66 million, marking a new position in the biotechnology company. Institutional investors and hedge funds collectively own a significant 85.27% of Exelixis, which recently reported strong quarterly earnings exceeding estimates, …

Fidelity (FDBC) Financial Results: The Company Releases Its Current Earnings Data in Latest Trading; Closing Reaction: Shares Finish 1.45% Up in the Latest Session - Capex Guidance

Top Gainers & Losers on 19 Aug: Netweb Tech, Bata, Reliance Power, Bharat Dynamics, Tata Chemicals among top losers

Ontario Teachers Pension Plan Board Invests $105.98 Million in Pembina Pipeline Corp. $PBA

The Ontario Teachers' Pension Plan Board has invested $105.98 million in Pembina Pipeline Corp. by acquiring 2.29 million shares, representing 0.39% of the company. This makes Pembina Pipeline the 22nd largest holding for the pension fund. Other institutional investors have also recently modified their …

Pembina (PBA) Q2 2026 Earnings: EPS Clears the Reported Estimate in the Current Update; Price Reaction: Shares Finish 1.44% Up in Latest Trading - Post-Earnings Drift

AZRG: Q2 2026 delivered stable financials, robust segment growth, and a strong development pipeline

Belite Bio Number of Employees 2026 | Employee Count & Headcount Data

Belite Bio, Inc. (NASDAQ: BLTE) had approximately 50 employees worldwide as of March 2026, representing a 232.6% growth from 2023. The company is actively hiring, with 1 active job posting in 2026, and its workforce is primarily concentrated in North America. The average salary …

Eli Lilly and Company $LLY Shares Purchased by Midwest Trust Co

Midwest Trust Co increased its stake in Eli Lilly and Company by 4.8% in the second quarter, bringing its holdings to 68,243 shares valued at approximately $81.9 million. The article notes that Eli Lilly reported strong quarterly results, with earnings of $8.38 per share …

Fidelity National Financial Inc. Buys New Shares in Textron Inc. $TXT

Fidelity National Financial Inc. has acquired a new position in Textron Inc. (NYSE:TXT), purchasing 300,000 shares valued at approximately $27.5 million, making Textron its fourth-largest holding. Textron recently surpassed quarterly earnings expectations and raised its fiscal 2026 guidance. Despite opening below analyst price targets, …

How Melisron's Rising Sales but Falling Earnings Will Impact Melisron (TASE:MLSR) Investors

5,669,902 Shares in Pembina Pipeline Corp. $PBA Bought by Deutsche Bank AG

Deutsche Bank AG has acquired a new stake of 5,669,902 shares in Pembina Pipeline Corp. (NYSE:PBA), valued at approximately $262.23 million, making them owners of about 0.98% of the company. Other institutional investors have also recently adjusted their holdings in Pembina Pipeline. The company …

Fidelity National Financial Inc. Purchases New Position in Oracle Corporation $ORCL

Fidelity National Financial Inc. has acquired a new position in Oracle Corporation, purchasing 104,000 shares valued at approximately $15.2 million, making Oracle 0.5% of its portfolio. Oracle exceeded its quarterly expectations with $2.11 EPS and $19.18 billion in revenue, and analysts generally maintain a …

Lilly Is Trailing In Obesity Pills; How Long Will That Last?

Eli Lilly (LLY) and Novo Nordisk (NVO) are engaged in a significant rivalry within the weight-loss drug market, projected to reach $200 billion. Both companies have successfully developed injectable GLP-1 agonists; however, the development of oral weight-loss pills could mark a major turning point …

FELIX Gold Up 10% – Here's Why This Antimony Play Is Gaining Attention

Total debt per share of Pembina Pipeline Corp. – OTC:PPLOF

This article focuses on the "Total debt per share" metric for Pembina Pipeline Corp. (OTC:PPLOF), as presented on TradingView. It appears to be a financial data page rather than an analytical piece, highlighting the value, change, and percentage change of this specific financial indicator.

Felix Gold (ASX:FXG) Climbs 12% After US Backs Antimony Pilot Funding

Felix Gold (ASX:FXG) Jumps 11.77% as Alaska Antimony Extraction Keeps the Market Engaged

Belite (BLTE) Earnings Brief: EPS Falls Short of Its Estimate on the Day; Market Read: Shares Finish 0.39% Down in the Current Update - Guidance Revision Trend

Belite (BLTE) Earnings Brief: EPS Falls Short of Its Estimate on the Day; Market Read: Shares Finish 0.39% Down in the Current Update - One-Time Gain Impact

ERCİYAS ÇELİK BORU SANAYİ A.Ş.(ERCB) Katılım Finansı İlkeleri Bilgi Formu 18 Ağustos 2026

Fidelity National Financial Q2 Call Highlights Strong Title

Why Eli Lilly (LLY) Stock Is Up Today

Why Eli Lilly (LLY) Stock Is Up Today What Happened? Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3% in the afternoon session after the company announced two deals, acquiring rights to a preclinical Alzheimer's drug and entering a collaboration for an ion …

Reliance Worldwide posts lower FY26 profit, boosts cash flow amid Brookfield bid

Reliance Worldwide Profit Slumps on Restructuring as Brookfield Tables Takeover Proposal

Reliance Worldwide Hit by Restructuring Charges as Margins Squeezed

Eli Lilly (LLY) Adds Neuroscience And Lung Cancer Research Deals

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Eli Lilly (NYSE: LLY) announced new global collaborations focused on ion channel drug discovery with OmniAb and a trial partnership with Amplia Therapeutics …

Eli Lilly and Company (NYSE:LLY) Stock Price Up 3.7% - What's Next?

Eli Lilly and Company (NYSE:LLY) shares increased by 3.7% to approximately $1,227, driven by optimism regarding its oral obesity drug prospects and positive developments for its next-generation candidate, retatrutide. The company is also expanding its pipeline through collaborations, including an ion-channel program with OmniAb …

Fidelity National Information Services (FIS) Could Be 20% Undervalued Following Strong Earnings

Fidelity National Information Services (FIS) is considered 19.8% undervalued with a fair value of $51.04, despite a recent share price decline. The company reported strong Q2 earnings and expanded its Digital One Commercial banking platform into APAC, alongside introducing new AI-powered fintech solutions. Analysts …

Bridgeline Digital posts $3.9M revenue in Q3 FY2026, narrows quarterly net loss to $0.5M

Bridgeline Digital reported total revenue of $3.9 million for Q3 FY2026, with subscription revenue at $3.1 million. The company narrowed its net loss to $0.5 million for the quarter, an improvement from $0.8 million a year prior. Key business highlights included a record-tying number …

Eli Lilly and Co(LLY.US) Officer Sells US$7.64 Million in Common Stock

An officer at Eli Lilly and Co (LLY.US) sold 9,936 shares of common stock for a total of $7.64 million on August 16, 2026, at an average price of $769.19 per share. This transaction was disclosed in a Form 4 filing with the SEC. …

Elicio (ELTX) Financial Update: Reported EPS Misses Expectations for This Review; Reaction Snapshot: Shares Move Higher 2.98% in Latest Trading - Share Dilution Risk

Helios (HLIO) Quarterly Figures: The EPS Result Is Above Expectation in the Latest Reading; Share-Price Check

Eli Lilly and Co Stock (LLY) Moved Up by 3.19% on Aug 18: What Signal Does It Send?

Eli Lilly and Co (LLY) stock rose 3.19% on August 18, driven by strong second-quarter earnings, an upgraded full-year outlook, and high demand for its Mounjaro and Zepbound treatments. Analysts have issued "Buy" ratings with an average price target of $1296.81, reflecting investor confidence …